| Investment Objective: |
State Street SPDR S&P China ETF seeks to track the performance of the S&P China BMI Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. Under normal market conditions, the Fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the Index and in depositary receipts (including American Depositary Receipts ("ADRs") or Global Depositary Receipts ("GDRs")) based on securities comprising the Index. The Index is a float-adjusted market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in China available to foreign investors. The Index also may include equity securities issued by companies incorporated in Mainland China that are denominated and currently traded in Renminbi on the Shanghai or Shenzhen Exchanges via the Shanghai-Hong Kong Stock Connect or Shenzhen-Hong Kong Stock Connect facilities (commonly known as "A Shares" or "China A Shares"). The Index component securities are a subset, based on region, of component securities included in the S&P Global BMI (Broad Market Index). |
